Skip to main content.

Pharmacology

Picture of Katherine  Eban

Some years ago, I began hearing from my sources that I should investigate the generic drug industry. A generic drug boom was underway and it had led to a gold-rush mentality, they said. There seemed no good way into this nebulous topic, and no way to assess the actual quality of U.S. generic drugs.

Picture of Susan  Abram

The makers of popular drugs like Advair, Cymbalta, Viagra and Zoloft have physicians, psychiatrists, and medical school faculty members across California on their payrolls. Does this influence prescribing patterns?

Picture of William Heisel

Bob Pack had some interesting ideas for how to improve California’s prescription drug tracking system (CURES). Most of them remain just that: interesting ideas.

Picture of William Heisel

A grieving father set out to create a system that might prevent other lives from being lost at the hands of a drug-dazed driver. Ten years later, he's still waiting for the system he created to be fully realized.

Picture of William Heisel

How does a doctor become a top prescriber of a psychiatric drug in one state’s Medicaid program? A "stunned" California psychiatrist tries to figure out why.

Picture of William Heisel

Reporters sometimes treat medicine as if newer is always better. It's not. Here's how to accurately report on the potential harms of a new treatment.

Picture of William Heisel

The most exciting exchange erupting on Twitter last week wasn’t about Kony 2012. Or Nandito Ako. It was about NNT — number needed to treat.

Picture of Gergana Koleva

A confluence of factors including an inflexible regulatory enviroment that discourages research and discovery, a paltry research pipeline for drugs for the most serious illnesses, and a tendency for physicians to unnecessarily prescribe antibiotics for routine aches and pains is largely responsible for the rise of antibiotic-resistant infections in humans, speakers at a major conference on infectious diseases this week announced.

Picture of Angilee Shah

Prescription drug abuse, contraception, psychiatry and obesity -- today in the Daily Briefing we look at some of the biggest health stories from fresh angles.

Picture of Andrew Schorr

Journalists from big name organizations better move over. The notebook or microphone next to you at medical conferences is now likely to be in the hand of someone living with the diagnosis being discussed.

Pages

Announcements

The nation's top infectious disease specialist will join us for a conversation with national health reporter Dan Diamond of The Washington Post. We’ll talk about the evolving threat posed by monkeypox, the current state of the COVID pandemic, and broader lessons on how we respond to emerging diseases. Sign-up here!

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth